These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 34102381)
21. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Xiong C; Roe CM; Buckles V; Fagan A; Holtzman D; Balota D; Duchek J; Storandt M; Mintun M; Grant E; Snyder AZ; Head D; Benzinger TL; Mettenburg J; Csernansky J; Morris JC Arch Neurol; 2011 Oct; 68(10):1313-9. PubMed ID: 21987546 [TBL] [Abstract][Full Text] [Related]
22. Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline. Stonnington CM; Velgos SN; Chen Y; Syed S; Huentelman M; Thiyyagura P; Lee W; Richholt R; Caselli RJ; Locke DEC; Lu B; Reiman EM; Su Y; Chen K J Alzheimers Dis; 2020; 78(2):721-734. PubMed ID: 33044176 [TBL] [Abstract][Full Text] [Related]
23. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease. Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156 [TBL] [Abstract][Full Text] [Related]
34. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Ellis KA; Bush AI; Darby D; De Fazio D; Foster J; Hudson P; Lautenschlager NT; Lenzo N; Martins RN; Maruff P; Masters C; Milner A; Pike K; Rowe C; Savage G; Szoeke C; Taddei K; Villemagne V; Woodward M; Ames D; Int Psychogeriatr; 2009 Aug; 21(4):672-87. PubMed ID: 19470201 [TBL] [Abstract][Full Text] [Related]
35. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study. Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796 [TBL] [Abstract][Full Text] [Related]
36. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease. Ng KP; Pascoal TA; Mathotaarachchi S; Chung CO; Benedet AL; Shin M; Kang MS; Li X; Ba M; Kandiah N; Rosa-Neto P; Gauthier S; Neurology; 2017 May; 88(19):1814-1821. PubMed ID: 28404803 [TBL] [Abstract][Full Text] [Related]
37. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Wirth M; Oh H; Mormino EC; Markley C; Landau SM; Jagust WJ Alzheimers Dement; 2013 Nov; 9(6):687-698.e1. PubMed ID: 23474040 [TBL] [Abstract][Full Text] [Related]
38. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β. Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000 [TBL] [Abstract][Full Text] [Related]
39. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D; Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466 [TBL] [Abstract][Full Text] [Related]
40. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging. Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]